Evidence map›Paper›PMID 32526944›Full record

ReviewBiomolecules2020

Marine-Derived Surface Active Agents: Health-Promoting Properties and Blue Biotechnology-Based Applications.

Ioannis Anestopoulos, Despina-Evgenia Kiousi, Ariel Klavaris, Monica Maijo, Annabel Serpico, Alba Suarez, Guiomar Sanchez, Karina Salek, Stylliani A Chasapi, Aikaterini A Zompra and 6 more

Open access · goldAbstract readReview
In one paragraph

Review in Biomolecules, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
0.6field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 5 institutions in 4 countries.

Ioannis AnestopoulosDepartment of Molecular Biology & Genetics, Democritus University of Thrace, 68100 Alexandroupolis, Greece.ORCID 0000-0003-2052-8470
Despina-Evgenia KiousiDepartment of Molecular Biology & Genetics, Democritus University of Thrace, 68100 Alexandroupolis, Greece.
Ariel KlavarisDepartment of Molecular Biology & Genetics, Democritus University of Thrace, 68100 Alexandroupolis, Greece.
Monica MaijoDivision of Health & Biomedicine, LEITAT Technological Centre, 08005 Barcelona, Spain.
Annabel SerpicoDivision of Health & Biomedicine, LEITAT Technological Centre, 08005 Barcelona, Spain.ORCID 0000-0001-7095-4035
Alba SuarezDivision of Health & Biomedicine, LEITAT Technological Centre, 08005 Barcelona, Spain.
Guiomar SanchezDivision of Health & Biomedicine, LEITAT Technological Centre, 08005 Barcelona, Spain.
Karina SalekInstitute of Mechanical, Process & Energy Engineering, Heriot Watt University, Edinburgh EH14 4AS, UK.ORCID 0000-0003-4837-7109
Stylliani A ChasapiDepartment of Pharmacy, University of Patras, 26504 Patra, Greece.
Aikaterini A ZompraDepartment of Pharmacy, University of Patras, 26504 Patra, Greece.
Alex GalanisDepartment of Molecular Biology & Genetics, Democritus University of Thrace, 68100 Alexandroupolis, Greece.ORCID 0000-0001-9991-3173
Georgios A SpyrouliasDepartment of Pharmacy, University of Patras, 26504 Patra, Greece.ORCID 0000-0003-1799-3312
Lourdes GombauDivision of Health & Biomedicine, LEITAT Technological Centre, 08005 Barcelona, Spain.
Stephen R EustonInstitute of Mechanical, Process & Energy Engineering, Heriot Watt University, Edinburgh EH14 4AS, UK.
Aglaia PappaDepartment of Molecular Biology & Genetics, Democritus University of Thrace, 68100 Alexandroupolis, Greece.
Mihalis I PanayiotidisDepartment of Applied Sciences, Northumbria University, Newcastle Upon Tyne NE1 8ST, UK.
Democritus University of Thrace · GRLeitat Technological Center · ESUniversity of Patras · GRHeriot-Watt University · GBNorthumbria University · GB

Funding

Horizon 2020 Framework Programme 635340 MARISURF
6 · The paper itself

Abstract

Surface active agents are characterized for their capacity to adsorb to fluid and solid-water interfaces. They can be classified as surfactants and emulsifiers based on their molecular weight (MW) and properties. Over the years, the chemical surfactant industry has been rapidly increasing to meet consumer demands. Consequently, such a boost has led to the search for more sustainable and biodegradable alternatives, as chemical surfactants are non-biodegradable, thus causing an adverse effect on the environment. To these ends, many microbial and/or marine-derived molecules have been shown to possess various biological properties that could allow manufacturers to make additional health-promoting claims for their products. Our aim, in this review article, is to provide up to date information of critical health-promoting properties of these molecules and their use in blue-based biotechnology (i.e., biotechnology using aquatic organisms) with a focus on food, cosmetic and pharmaceutical/biomedical applications.

Indexed as

BiotechnologyHealthAnimalsHumansSurface-Active AgentsSurface-Active Agentsanti-aginganti-canceranti-inflammatoryanti-microbialanti-oxidantanti-viralbiosurfactantsblue biotechnologysurface active agents

Identifiers

PMID32526944
PMCPMC7355491
OpenAlexW3035311131

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.